Logo image of EXL.DE

EXASOL AG (EXL.DE) Stock Fundamental Analysis

FRA:EXL - Deutsche Boerse Ag - DE000A0LR9G9 - Common Stock - Currency: EUR

2.87  -0.01 (-0.35%)

Fundamental Rating

5

EXL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 100 industry peers in the Software industry. EXL has a great financial health rating, but its profitability evaluates not so good. EXL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EXL was profitable.
In the past year EXL had a positive cash flow from operations.
In the past 5 years EXL reported 4 times negative net income.
EXL had negative operating cash flow in 4 of the past 5 years.
EXL.DE Yearly Net Income VS EBIT VS OCF VS FCFEXL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.19%, EXL is in line with its industry, outperforming 55.00% of the companies in the same industry.
The Return On Equity of EXL (5.02%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.19%
ROE 5.02%
ROIC N/A
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
EXL.DE Yearly ROA, ROE, ROICEXL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

EXL has a Profit Margin (0.58%) which is comparable to the rest of the industry.
With an excellent Gross Margin value of 93.86%, EXL belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
EXL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.58%
GM 93.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
EXL.DE Yearly Profit, Operating, Gross MarginsEXL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

EXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXL remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EXL has more shares outstanding
EXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXL.DE Yearly Shares OutstandingEXL.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EXL.DE Yearly Total Debt VS Total AssetsEXL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

EXL has an Altman-Z score of 4.52. This indicates that EXL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.52, EXL is in the better half of the industry, outperforming 63.00% of the companies in the same industry.
There is no outstanding debt for EXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.52
ROIC/WACCN/A
WACC7.65%
EXL.DE Yearly LT Debt VS Equity VS FCFEXL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

EXL has a Current Ratio of 23.06. This indicates that EXL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 23.06, EXL belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
A Quick Ratio of 23.06 indicates that EXL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 23.06, EXL belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 23.06
Quick Ratio 23.06
EXL.DE Yearly Current Assets VS Current LiabilitesEXL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

EXL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.68%, which is quite impressive.
Looking at the last year, EXL shows a quite strong growth in Revenue. The Revenue has grown by 12.76% in the last year.
Measured over the past years, EXL shows a quite strong growth in Revenue. The Revenue has been growing by 12.89% on average per year.
EPS 1Y (TTM)102.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.91%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%16.25%

3.2 Future

Based on estimates for the next years, EXL will show a very strong growth in Earnings Per Share. The EPS will grow by 306.20% on average per year.
Based on estimates for the next years, EXL will show a quite strong growth in Revenue. The Revenue will grow by 10.03% on average per year.
EPS Next Y600%
EPS Next 2Y306.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.21%
Revenue Next 2Y7.66%
Revenue Next 3Y8.23%
Revenue Next 5Y10.03%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EXL.DE Yearly Revenue VS EstimatesEXL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
EXL.DE Yearly EPS VS EstimatesEXL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 287.00 indicates a quite expensive valuation of EXL.
Compared to the rest of the industry, the Price/Earnings ratio of EXL is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.28, EXL is valued quite expensively.
The Price/Forward Earnings ratio is 40.59, which means the current valuation is very expensive for EXL.
EXL's Price/Forward Earnings ratio is in line with the industry average.
EXL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 287
Fwd PE 40.59
EXL.DE Price Earnings VS Forward Price EarningsEXL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXL.
EXL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 64.13
EV/EBITDA 31.53
EXL.DE Per share dataEXL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXL's earnings are expected to grow with 306.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y306.2%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXASOL AG

FRA:EXL (7/2/2025, 7:00:00 PM)

2.87

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-05 2025-05-05
Earnings (Next)08-12 2025-08-12
Inst Owners13.19%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap77.15M
Analysts83.33
Price Target5.2 (81.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.37%
PT rev (3m)7.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.78%
Valuation
Industry RankSector Rank
PE 287
Fwd PE 40.59
P/S 1.95
P/FCF 64.13
P/OCF 55.78
P/B 16.89
P/tB 27
EV/EBITDA 31.53
EPS(TTM)0.01
EY0.35%
EPS(NY)0.07
Fwd EY2.46%
FCF(TTM)0.04
FCFY1.56%
OCF(TTM)0.05
OCFY1.79%
SpS1.47
BVpS0.17
TBVpS0.11
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.19%
ROE 5.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.58%
GM 93.86%
FCFM 3.04%
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
F-Score8
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 8.38%
Cap/Sales 0.45%
Interest Coverage N/A
Cash Conversion 70.11%
Profit Quality 524.64%
Current Ratio 23.06
Quick Ratio 23.06
Altman-Z 4.52
F-Score8
WACC7.65%
ROIC/WACCN/A
Cap/Depr(3y)7.45%
Cap/Depr(5y)49.4%
Cap/Sales(3y)0.53%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.91%
EPS Next Y600%
EPS Next 2Y306.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.76%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%16.25%
Revenue Next Year8.21%
Revenue Next 2Y7.66%
Revenue Next 3Y8.23%
Revenue Next 5Y10.03%
EBIT growth 1Y97.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3850.5%
EBIT Next 3Y335.34%
EBIT Next 5YN/A
FCF growth 1Y118.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y121.98%
OCF growth 3YN/A
OCF growth 5Y-9.08%